# Larinova — Complete Project Audit
**Date:** April 18, 2026  
**Prepared for:** Gabriel  
**Scope:** All 12 files in workspace, strategic direction review, Indonesia + India expansion, git sync setup

---

## 1. Full File Inventory

| File | Type | Purpose |
|---|---|---|
| `CLAUDE.md` | Knowledge base | Sales context, outreach scripts, objection handling |
| `Presentasi Larinova.html` | Interactive HTML presentation | 12-slide Indonesian pitch deck with audio narration |
| `Larinova_Pricing_Page_Mockup.html` | HTML mockup | Pricing page with billing toggle (Indonesian) |
| `email_larinova_template.html` | HTML email template | Cold/warm email template (Indonesian) |
| `whatsapp_templates.html` | HTML template tool | 6 WhatsApp templates with copy-to-clipboard |
| `Larinova_Discovery_Form.pdf` | 2-page PDF form | Doctor discovery form (Indonesian) |
| `Larinova_Discovery_Form_EN.pdf` | 2-page PDF form | Doctor discovery form (English) |
| `Larinova_Analisis_Harga_Pasar.xlsx` | Spreadsheet | Market data + pricing strategy (2 sheets) |
| `Larinova_LENGKAP_FINAL.xlsx` | Spreadsheet | Cold leads database — 51 hospitals/clinics |
| `Midwifery_Market_Opportunity_Gabriel.pptx` | 7-slide PPTX | English strategy deck on midwifery segment |
| `Riset_Pasar_Kebidanan_Larinova_v2.docx` | Research report | Detailed midwifery market research (Indonesian) |
| `Laporan_Feedback_Kebidanan_Larinova.docx` | Field feedback report | Elisa (bidan) interview + feature recommendations |

---

## 2. Document-by-Document Feedback

---

### `CLAUDE.md` — Context Document
**Rating: Strong ✅**

This is solid. The messaging framework, outreach sequence, objection handling, and positioning are well-constructed and internally consistent. The value prop table is particularly clean.

**Issues:**
- Entirely Indonesia-specific. No India context at all — relevant because you've mentioned India expansion.
- The outreach sequence here (7 steps) doesn't match the presentation's version (5 steps). Minor, but creates inconsistency if someone reads both.
- Midwifery/bidan segment is not mentioned here at all, despite being a major focus of multiple other documents. The context doc needs updating to reflect the segment work.

---

### `Presentasi Larinova.html` — 12-Slide Interactive Presentation
**Rating: Genuinely impressive ✅✅**

This is the best piece of work in the folder. A fully interactive HTML slide deck with audio narration (Web Speech API), keyboard navigation, progress bar, and smooth transitions. The design is professional — dark navy/teal palette, clear hierarchy. Content sequence (Problem → Solution → AI Scribe → Features → Why → Target → CTA → Approach → WA Templates → Objection Handling → Close) is logical and persuasive.

**Issues:**
- Closing slide: "Untuk dokter Indonesia, oleh teknologi Indonesia 🇮🇩" — locks the brand identity to Indonesia only. If expanding to India, a separate version will be needed.
- No mention of the midwifery segment at all. Given the research depth on bidan, this seems like a strategic miss.
- "No direct competitor for AI Scribe in Indonesian" is your core claim — confirm this is still accurate as of April 2026. If any competitor has launched, this slide needs updating.
- Narration on Slide 9 says 5 approach steps; CLAUDE.md has 7. Fix the mismatch.

---

### `Larinova_Pricing_Page_Mockup.html` — Pricing Page
**Rating: Strong ✅**

Well-designed, functional, and internally consistent with the CLAUDE.md pricing strategy. The annual/monthly billing toggle works. The enterprise tier is handled correctly (no price listed, just "Contact Us"). The 4-tier structure (Starter IDR 149k → Business IDR 2.499M) matches the market analysis spreadsheet exactly.

**Issues:**
- **Math error (minor):** In the monthly view, each plan shows "= IDR X/tahun" — but the displayed annual total for Starter is IDR 1,490,000 which is 149,000 × 10, not × 12. If a doctor is paying monthly, the real annual cost is 149,000 × 12 = 1,788,000. The 1,490,000 figure only makes sense as the *annual plan* price. This is confusing on the monthly view and should be cleaned up.
- The nav button and all CTA buttons have no real links — they don't go anywhere yet. These need to be wired to the actual sign-up form when it's ready.
- Trust badge "Support 7 hari seminggu" — make sure this is actually deliverable before publishing.

---

### `email_larinova_template.html` — Email Template
**Rating: Good ✅ (with one notable issue)**

Clean HTML email design, appropriate width (600px), good use of visual hierarchy (header → greeting → video thumbnail → feature bullets → CTA → footer). The feature list maps well to the actual product.

**Issues:**
- **Color inconsistency:** The email header uses blue (#1a6ee8). The presentation and pricing page use teal (#00B8A9 / #2E6DA4). These are different enough that they'll look like different brands when a doctor sees them in sequence. Pick one palette and stick to it.
- All links are placeholders (`href="#"`). The video link and sign-up link both need real URLs before this can be sent.
- No WhatsApp number and no email address in the footer — just placeholders.
- No mobile media query. Most Indonesian doctors will open this on mobile — test rendering on small screens.

---

### `whatsapp_templates.html` — WA Template Library
**Rating: Excellent ✅✅**

The most immediately practical document in the folder. 6 templates covering the full sequence (warm intro → cold intro → send video → follow-up → post sign-up → referral ask), with phone frame mockups and one-click copy buttons. The copy function works correctly. The bold formatting tip at the bottom (using *asterisks* for bold in WhatsApp) is a useful practical detail.

**Issues:**
- Template 3 still has `[LINK VIDEO DI SINI]` — needs the actual video link.
- No India-specific templates.

---

### `Larinova_Discovery_Form.pdf` (Indonesian) + `Larinova_Discovery_Form_EN.pdf` (English)
**Rating: Good ✅**

Both are clean, well-structured, 2-page forms. The questions are strategically designed — they quantify pain (how many hours on admin, how often do you have unfinished notes) in a way that sets up the Larinova value prop. The offer of 1-month free access as a reward for completing the form is smart.

**Issues:**
- These are print PDFs — there's no digital/fillable version linked. For a digital-first outreach strategy, this needs to exist as a Google Form or Typeform with the larinova.id URL live.
- The English version still has "Full Bahasa Indonesia support" as a trust badge at the bottom. Odd placement for an English-language version — if this is for English-speaking decision-makers or India, it's irrelevant.
- Section 5 (free-text "if you could change one thing...") will have near-zero completion rate in a paper form. Consider making it a dropdown.
- No version for midwives/bidans, despite the segment research.

---

### `Larinova_Analisis_Harga_Pasar.xlsx` — Market Data + Pricing Strategy
**Rating: Very Strong ✅✅**

This is the most analytically rigorous document in the folder. Market data is sourced from actual annual reports (Siloam AR 2023, Mayapada AR 2024, BPS, Kemenkes SIRS), not just estimates. The pricing rationale (1–3% of monthly revenue) is a solid anchor. The ROI simulation is compelling:

- Dokter solo: saves IDR 9,750,000/month in time → costs IDR 149,000 = **65x ROI**
- Klinik kecil: saves IDR 58,500,000/month → costs IDR 399,000 = **147x ROI**

These are powerful numbers. Use them in outreach.

**Issues:**
- The 15 min/patient assumption is your key number — it's not validated. One skeptical doctor challenging this could undermine the whole ROI pitch. You need to back it up with a data source or field validation (e.g., "In our pilot with [doctor], time per consultation dropped from X to Y").
- IDR 150,000/hour as the doctor time value is conservative. Specialist doctors (cardiologist, dermatologist) bill at significantly higher rates. Consider adding a "specialist" column in the ROI table showing the higher-end case.
- No India equivalent. If you're expanding to India, you need a parallel analysis in INR.
- Sheet is duplicated — "Data Pasar Indonesia" appears twice in the workbook.

---

### `Larinova_LENGKAP_FINAL.xlsx` — Cold Leads Database
**Rating: Needs Work ⚠️**

A list of 51 hospitals and clinics with phone/email/WhatsApp. Useful starting point.

**Issues:**
- **Wrong target profile.** Your CLAUDE.md says the easiest early targets are solo practitioners and small clinics — but this database is almost entirely large hospitals and hospital chains. Large institutions have longer decision cycles, multiple stakeholders, and procurement processes. This database is more useful for the Enterprise tier (future), not the current free-adoption phase.
- **No CRM structure.** The sheet has no columns for: Contact Date, Response, Status, Next Action, Assigned To. It's a raw list, not a working sales tool. You'll lose track of conversations within a week.
- **Weak WhatsApp coverage.** Many rows have no WA number — just a phone or website form. Since WA is the primary channel, leads without WA numbers should be deprioritized or separately flagged.
- **No individual names.** For institutional outreach, "Siloam Hospital Kebon Jeruk" is not a lead — a named medical director or operations manager at that hospital is a lead. Without a specific person, you're just cold-calling a switchboard.
- No midwife/bidan leads despite the research.
- No India leads.

---

### `Riset_Pasar_Kebidanan_Larinova_v2.docx` + `Laporan_Feedback_Kebidanan_Larinova.docx`
**Rating: Solid research, needs consolidation ✅**

The v2 research report is the more complete version — it covers market scale (300k+ registered midwives), pain points, mandatory forms (ANC, Partograf, Nifas, Immunization), regulatory requirements (SATUSEHAT, BPJS), competitive landscape, and feature recommendations. The Elisa interview is a genuine data point.

The feedback report (`Laporan_Feedback_Kebidanan_Larinova.docx`) is an earlier, shorter version of essentially the same content.

**Issues:**
- **Section 5 ("Rekomendasi Fitur") in the v2 report is blank.** The section exists in the table of contents but the content is missing. This needs to be filled in — especially since the PPTX covers feature recommendations well.
- **These two documents overlap ~70%.** Consolidate into one definitive midwifery research document. Having two creates confusion about which is current.
- The field research is from a single source (Elisa). The document acknowledges this — but it needs 3-5 more midwives before drawing firm conclusions.

---

### `Midwifery_Market_Opportunity_Gabriel.pptx` — 7-Slide English Deck
**Rating: Best strategic document in the folder ✅✅**

This is clean, well-structured, and makes a compelling strategic case. The SATUSEHAT regulatory urgency angle is the strongest hook — it converts a "nice to have" into a "must have" for compliance. The competitive landscape slide (showing that no competitor has the full combination) is particularly strong.

**Issues:**
- "<5% midwives using digital records today" — this stat needs a citation. If challenged, you need a source.
- All Larinova columns are labeled "proposed" in the competitive landscape. This is honest but signals that the midwifery features don't exist yet. If presenting to investors or potential enterprise partners, this could be a concern.
- The 7 "next steps" are still pending as of April 2026 (Elisa validation, 3-5 more interviews, etc.). What's the current status of these?

---

## 3. Cross-Cutting Issues

### A. Critical: Most Assets Are Still Placeholders
The demo video link, sign-up form link, WhatsApp number, email address, and website URL are all `[placeholder]` or `href="#"` across every document. You cannot run outreach without these. This is the single biggest blocker.

**Priority action:** Lock down the demo video and sign-up form link. Everything else depends on them.

### B. Major: No India Content
Every document in this folder is Indonesia-specific. The expansion to India means you're essentially building a new product GTM from scratch:
- India's regulatory environment: ABDM (Ayushman Bharat Digital Mission), not SATUSEHAT
- Language: Hindi-first or English (not Bahasa Indonesia)
- Communication channels: WhatsApp penetration is high in India too, but the outreach tone and style are different
- Market structure: significantly different doctor/clinic density, urban vs. tier-2 city dynamics
- Pricing: INR vs IDR (the absolute numbers will need recalibration)

The "Bahasa Indonesia" positioning is your core differentiator in Indonesia. In India, you'd need a different angle — possibly "Hindi-first", "built for Indian healthcare workflows", or leveraging the ABDM compliance story the way you're leveraging SATUSEHAT in Indonesia.

### C. Significant: Midwifery Segment vs. Main Strategy
You've done substantial work on the midwifery (bidan) segment — 2 docx reports, 1 PPTX, significant regulatory research. But none of the outreach materials (WA templates, email, presentation, discovery forms) reflect this. There's a strategic decision to make:
- Is midwifery a **parallel segment** you're actively pursuing now?
- Or is it a **future roadmap item** that needs product development before GTM?

If it's being pursued now, the outreach materials need bidan-specific versions. If it's future, the research is valuable but shouldn't distract from the current doctor-focused outreach.

### D. Moderate: Color/Brand Inconsistency
- Email template: blue (#1a6ee8)
- Presentation + pricing page: teal (#00B8A9 / #2E6DA4)

These look like different products to a doctor receiving an email and then seeing the presentation. Standardize on one color palette.

### E. Moderate: No CRM / Lead Tracking
You have a cold leads list but no way to track outreach activity. Add these columns to the Excel at minimum: `Contact Date | Channel | Response | Status | Next Action | Notes`. Consider a lightweight CRM (Notion, Airtable, or even a second Excel sheet) before you scale outreach.

---

## 4. India Expansion: What You Need to Know

Expanding to India is a major undertaking, not a market extension. Here's the honest picture:

**What transfers from Indonesia:**
- Core product concept (AI Scribe + practice management)
- Pricing model logic (% of monthly revenue)
- WhatsApp as primary outreach channel (India has 500M+ WA users)
- Referral-driven doctor network dynamics

**What does NOT transfer:**
- All Bahasa Indonesia positioning — needs to be rebuilt for the Indian context
- SATUSEHAT compliance hook → replaced by ABDM compliance (Ayushman Bharat Digital Mission)
- Outreach scripts (language, cultural tone, formality level differ significantly)
- Pricing in IDR → needs INR recalibration
- Regulatory knowledge (different prescribing norms, different document requirements)

**India-specific competitive landscape:** Practo, Eka Care, Vezeeta (Middle East but expanding), and a range of EHR vendors are more established in India than the Indonesian market. The competitive moat needs to be re-established.

**Recommended approach for India:** Before building India-specific assets, do the same field research you did with Elisa — but with 5-10 Indian doctors across 2-3 cities (Chennai makes sense as your base). Validate that the pain points are the same before committing to an India GTM.

---

## 5. Git Sync Setup (Two Laptops)

This is the simplest solution and the right one. Here's the setup:

### Step 1: Initialize a Git repo in your folder
```bash
cd "/path/to/larinova indonesia"
git init
git add -A
git commit -m "Initial commit: all Larinova working documents"
```

### Step 2: Create a private GitHub repo
Go to github.com → New repository → Name it `larinova-workspace` → Set to **Private** → Don't initialize with README (you already have files).

### Step 3: Push from Laptop 1
```bash
git remote add origin https://github.com/YOUR_USERNAME/larinova-workspace.git
git branch -M main
git push -u origin main
```

### Step 4: Clone on Laptop 2
```bash
git clone https://github.com/YOUR_USERNAME/larinova-workspace.git
```

### Daily Workflow
On whichever laptop you're working on:
```bash
git pull          # get latest from the other laptop
# ... do work ...
git add -A
git commit -m "Brief description of what you changed"
git push
```

### Add a `.gitignore` to exclude junk files:
```
.DS_Store
.~lock.*
*.tmp
```

**Note:** Binary files (xlsx, pptx, pdf, docx) do get tracked by git, but diff/merge doesn't work on them — only the latest version. For these file types, git is just a sync/backup system, not a true version-control tool. That's fine for your use case.

If you want real-time sync (not commit-based), Dropbox or iCloud Drive is simpler. But for a project this size, git on GitHub is the right long-term choice.

---

## 6. Priority Action List

**This week (unblocking fundamentals):**
1. Get the demo video finalized and get a shareable link
2. Get the sign-up form live (larinova.id or a Typeform/Tally) and get the URL
3. Fill all `[placeholder]` links across every document
4. Set up git sync between the two laptops (30 min one-time task)

**This month (India + midwifery decisions):**
5. Decide: is midwifery being actively pursued now or is it future roadmap? Update the CLAUDE.md and outreach materials accordingly
6. If India expansion is within 3-6 months: do 5-10 doctor interviews in Chennai/Bangalore to validate pain points before building India-specific assets
7. Add CRM columns to the cold leads Excel and do the first outreach wave
8. Fix the email color palette to match the teal used in the presentation and pricing page
9. Add India context to CLAUDE.md (even a basic section) so the knowledge base is ready when India work starts
10. Consolidate the two midwifery docx files into one definitive document

**Nice to have:**
11. Add a midwife/bidan-specific discovery form PDF
12. Add a "Bidan" target row to the WhatsApp templates
13. Build out the cold leads database with more solo practitioners and small clinics (the actual easy targets right now)

---

*Audit completed: April 18, 2026*  
*All documents reviewed: CLAUDE.md, Presentasi Larinova.html, Larinova_Pricing_Page_Mockup.html, email_larinova_template.html, whatsapp_templates.html, Larinova_Discovery_Form.pdf, Larinova_Discovery_Form_EN.pdf, Larinova_Analisis_Harga_Pasar.xlsx, Larinova_LENGKAP_FINAL.xlsx, Midwifery_Market_Opportunity_Gabriel.pptx, Riset_Pasar_Kebidanan_Larinova_v2.docx, Laporan_Feedback_Kebidanan_Larinova.docx*
